- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02454816
Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in Colombia
Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in COLOMBIA
Global and regional initiatives have been launched for the dual elimination of mother-to-child transmission (MTCT) of HIV and syphilis. As one of the important components in the initiatives, early detection and timely intervention of pregnant women infected with HIV and/or syphilis is critical. In order to improve the number of women tested and treated, innovative strategies are needed.
Serologic tests are the diagnostic tests of choice for HIV and syphilis. There are two types of serological tests (treponemal and non-treponemal tests) for diagnosis of syphilis. These generally require venous blood for screening of symptomatic and asymptomatic patients. In addition, these tests are technically demanding, and require laboratory equipment which is not widely available in most resource-limited settings.
Recently, Rapid diagnostic tests (RDTs) that can be used at point-of-care for simultaneously detecting antibodies to HIV and syphilis (dual HIV & syphilis treponemalRDTs) using serum/plasma, venous whole blood, or finger-stick whole blood have been developed and are now commercially available.
In low-resource settings, a combination of two or three rapid diagnostic tests (RDTs), in which one screening test with a second test to confirm initial positive results or two RDTs in parallel with a third test as a tiebreaker for discordant samples, can be used to diagnose HIV on finger-stick blood. To date, there are few data on the implications of using these RDTs in the antenatal clinic settings, although they have been evaluated in laboratory-based studies and shown encouraging sensitivities and specificities as compared with reference laboratory tests.
The objective of this research is to assess the uptake of syphilis testing after the introduction of dual HIV/syphilis rapid testing as compared to single rapid syphilis testing in antenatal clinics in Colombia.
The secondary objectives of the study are: To determine the uptake of treatment of syphilis after the intervention, To determine the uptake of HIV testing in ANC attendees after the intervention, To explore the acceptability of dual HIV/syphilis RDTs by ANC attendees and health workers, To assess the organizational and socio-cultural advantages and barriers to introduction with a aim of sustainable adoption of dual HIV/syphilis RDTs in antenatal services, To determine the workload and cost implications of introduction of dual HIV/syphilis RDTs in antenatal services
Study Overview
Status
Intervention / Treatment
Detailed Description
Methods:
Desing: Cluster randomized trial including and quantitative component, a qualitative component (in-deep interviews)and a time and cost estimation component in the antenatal care setting.
Population: Primary health facilities (n=12) in Bogotá and Cali, Colombia. Eligibility criteria: Inclusion Criteria: Pregnant women attending first ANC visit at the study sites, or women not previously tested in this pregnancy,Women aged 14 years old or above, Any woman who has tested positive for HIV and/or syphilis in the past (will be permitted to enrol), Women providing a written informed consent.Exclusion Criteria: Women who have already been enrolled in this study, Women < 14 years of age, Women unable to provide informed consent.
Test to be evaluated: Each of the 12 institutions participating in the trial were assigned in a random way to rapid single test for HIV and Syphilis or dual rapid test HIV/syphilis. The brand of the rapid test selected for the study, passed throw a process of selection by the National Health Institute in Colombia, in order to choose the best test according to desirable performance and operational characteristics. The brand Standard Diagnostics the Bioline was donated to do the rapid test in the present study with pregnant women.
Analysis:
- CONSORT diagram for the cluster randomized trial will be shown.
- Primary analysis will be based on intention-to-treat principle, with no facility excluded from analysis after the random assignment.
- Baseline characteristics of clusters (facilities) and of the women enrolled in each arm will be provided.
- For qualitative variables frequencies and percentages will be reported. For quantitative normally distributed variables, the number of subjects, means and standard errors will be provided, while medians, interquartile range, minima and maxima will be reported for skewed non-normal quantitative variables.
- Because of the clustered nature of outcomes due to randomization to interventions based on clusters (facilities), the Generalized Estimating Equations (GEE) modelling, with binomial distribution and logit link, will be used to estimate the risk difference (RD) and odds ratio (OR) of Syphilis testing, Syphilis treatment and HIV testing uptake, with 95% Confidence Interval, adjusted for clustering, between interventions arms A and B. This model will adjust for any important baseline factors, including whether any testing in Syphilis or HIV was ever done previously.
- Intra-cluster correlations (ICC) for overall, as well as ICCs stratified for important baseline factors of interest, will be estimated.
- Two-sided tests and 5% significance levels will be used, and 95% confidence intervals for all relevant parameters. SAS statistical packages will be used for the statistical analyses.
Expected results: The results of the study will be used in the design of strategies of policies/national o local guidelines or even screening antenatal programs for HIV and syphilis, the development of the best practice to the adoption of the rapid test for HIV and Syphilis. The information collected will be used to share the experience and the lessons learned to other countries in order to development guidelines of global, regional and national policies to implement in order to impact the transmission of maternal-child HIV and syphilis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Valle Del Cauca
-
Cali, Valle Del Cauca, Colombia
- Hospital Carlos Holmes Trujillo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women attending first ANC visit at the study sites, or women not previously tested in this pregnancy
- Women aged 14 years old or above
- Any woman who has tested positive for HIV and/or syphilis in the past (will be permitted to enrol)
- Women providing a written informed consent
Exclusion Criteria:
- Women who have already been enrolled in this study
- Women < 14 years of age
- Women unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Single HIV RDT and single syphilis RDT
It is a diagnostic intervention, at the cluster level This arm includes a single (separate) rapid test for HIV and Syphilis.
In this case pregnant women enrolled are sampled with two drops of blood (one for each cassette).
Positive patients for syphilis are treated immediately and reactive patients for HIV continue with their diagnostic algorithm, in any case patients receive appropriate counseling
|
It is a diagnostic intervention, at the cluster level This arm includes a single (separate) rapid test for HIV and Syphilis.
In this case pregnant women enrolled are sampled with two drops of blood (one for each cassette).
Positive patients for syphilis are treated immediately and reactive patients for HIV continue with their diagnostic algorithm, in any case patients receive appropriate counseling
|
ACTIVE_COMPARATOR: Dual HIV/syphilis RDT
It is a diagnostic intervention, at the cluster level.
This arm includes a dual rapid test for HIV and syphilis, which means that in the same cassette will be available the information about the results for both conditions.
In this case pregnant women enrolled are sampled with one drop for the cassette, which is enough to get both of the results.
Positive patients for syphilis are treated immediately and reactive patients for HIV continue with their diagnostic algorithm, in any case patients receive appropriate counseling
|
It is a diagnostic intervention, at the cluster level.
This arm includes a dual rapid test for HIV and syphilis, which means that in the same cassette will be available the information about the results for both conditions.
In this case pregnant women enrolled are sampled with one drop for the cassette, which is enough to get both of the results.
Positive patients for syphilis are treated immediately and reactive patients for HIV continue with their diagnostic algorithm, in any case patients receive appropriate counseling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of participants in syphilis testing with SRDT compared to DRDT post intervention
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Differences in Number of participants with uptake of HIV testing between Arm A and Arm B.
Time Frame: 4 months
|
4 months
|
Number of participants with syphilis treatment between Arm A and Arm B
Time Frame: 4 months
|
4 months
|
Number of participants with uptake of syphilis treatment between Arm A and Arm B
Time Frame: 4 months
|
4 months
|
Number of participants with acceptability and feasibility of dual RDTand health care workers.
Time Frame: 4 months
|
4 months
|
Determine the workload and cost implications of the introduction of dual RDTs in antenatal services through a time/motion/cost exercise.
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIV2.0
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on Single HIV RDT and single syphilis RDT
-
Foundation for Innovative New Diagnostics, SwitzerlandBurnet Institute; Papua New Guinea Institute of Medical ResearchUnknownDiagnoses Disease | Plasmodium Falciparum Malaria | Pregnancy Malaria
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversidad de AntioquiaCompletedDiagnoses Disease | Plasmodium Falciparum | Pregnancy MalariaColombia
-
Ghana Health ServicesLondon School of Hygiene and Tropical MedicineCompleted
-
PATHCentro de Pesquisa em Medicina Tropical de RondoniaRecruiting
-
Harvard School of Public Health (HSPH)Clinton Health Access Initiative, Nigeria; Uganda Health Marketing Group; Innovations...Completed
-
Noguchi Memorial Institute for Medical ResearchGhana Health Service, Neglected Tropical Diseases ProgramCompletedOnchocerciasis | Lymphatic FilariasesGhana
-
University of CalgaryJimma University; Armauer Hansen Research Institute, Ethiopia; Amhara Public...RecruitingMalaria | Malaria in Pregnancy | Pregnancy MalariaCanada, Ethiopia
-
University of California, San FranciscoHealth Poverty Action; Center for Malariology, Parasitology, and Entomology; The...CompletedPlasmodium Falciparum MalariaLao People's Democratic Republic
-
Region StockholmRecruitingMalaria | Parasitic InfectionSweden
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Moi UniversityCompleted